BNO Licensee, Ironwood submits IND Application for Anti-Anxiety Drug
Fri, 9 Nov 2012 11:45am
BIONOMICS LIMITED (BNO)
Deborah Rathjen, CEO
Bionomics CEO, Deborah Rathjen talks with BRR about the filing of the IND application.